RETN and breast cancer: While several studies have shown increased systemic and breast tumor resistin levels among postmenopausal breast cancer patients to be positively associated with increasing BMI, poor tumor characteristics and impaired prognosis, an inverse association was recently reported among early onset breast cancer patients, independent of BMI (13, 35, 36).